APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Transmucosal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Transmucosal Drugs Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchOral Transmucosal Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Transmucosal Drugs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Oral Transmucosal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Transmucosal Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Transmucosal Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Oral Transmucosal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Transmucosal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Transmucosal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Transmucosal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Transmucosal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Transmucosal Drugs include Access Pharmaceutical Inc., Aquestive Therapeutics, Inc., Bristol-Myers Squibb Company, C.L Pharm, Cure Pharmaceutical, Eisai Co., Ltd., IntelGenx Corp., LTS Lohmann Therapie-Systeme AG and NAL Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Transmucosal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Transmucosal Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Transmucosal Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Transmucosal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Transmucosal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Transmucosal Drugs sales, projected growth trends, production technology, application and end-user industry.

Oral Transmucosal Drugs Segment by Company

Access Pharmaceutical Inc.

Aquestive Therapeutics, Inc.

Bristol-Myers Squibb Company

C.L Pharm

Cure Pharmaceutical

Eisai Co., Ltd.

IntelGenx Corp.

LTS Lohmann Therapie-Systeme AG

NAL Pharma

Otsuka Pharmaceutical Co., Ltd.

Soligenix

Viatris

ZIM Laboratories Limited

GlaxoSmithKline plc

Teva Pharmaceutical Industries Ltd.

Oral Transmucosal Drugs Segment by Type

Liquid Spray

Tablets

Gels

Films

Others

Oral Transmucosal Drugs Segment by Application

Cardiovascular Disorders

Diabetes

Acute Pain Managements

Others

Oral Transmucosal Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Transmucosal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Transmucosal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Transmucosal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Transmucosal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Transmucosal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Transmucosal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Transmucosal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Spray Major Manufacturers Table 3. Tablets Major Manufacturers Table 4. Gels Major Manufacturers Table 5. Films Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Oral Transmucosal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Cardiovascular Disorders Major Manufacturers Table 9. Diabetes Major Manufacturers Table 10. Acute Pain Managements Major Manufacturers Table 11. Others Major Manufacturers Table 12. Oral Transmucosal Drugs Industry Trends Table 13. Oral Transmucosal Drugs Industry Drivers Table 14. Oral Transmucosal Drugs Industry Opportunities and Challenges Table 15. Oral Transmucosal Drugs Industry Restraints Table 16. Global Oral Transmucosal Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Oral Transmucosal Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Oral Transmucosal Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Oral Transmucosal Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Oral Transmucosal Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Oral Transmucosal Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Oral Transmucosal Drugs Sales by Region (2021-2026) & (K Units) Table 23. Global Oral Transmucosal Drugs Sales by Region (2027-2032) & (K Units) Table 24. Global Oral Transmucosal Drugs Sales Market Share by Region (2021-2026) Table 25. Global Oral Transmucosal Drugs Sales Market Share by Region (2027-2032) Table 26. Global Oral Transmucosal Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Oral Transmucosal Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Oral Transmucosal Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Oral Transmucosal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Oral Transmucosal Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Oral Transmucosal Drugs Manufacturers, Product Type & Application Table 34. Global Oral Transmucosal Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Oral Transmucosal Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Oral Transmucosal Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Oral Transmucosal Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Oral Transmucosal Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Oral Transmucosal Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 44. Global Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 45. Global Oral Transmucosal Drugs Sales Market Share by Type (2021-2026) Table 46. Global Oral Transmucosal Drugs Sales Market Share by Type (2027-2032) Table 47. Global Oral Transmucosal Drugs Price by Type (2021-2026) & (US$/Unit) Table 48. Global Oral Transmucosal Drugs Price by Type (2027-2032) & (US$/Unit) Table 49. Global Oral Transmucosal Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Oral Transmucosal Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Oral Transmucosal Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Oral Transmucosal Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Oral Transmucosal Drugs Sales Market Share by Application (2021-2026) Table 58. Global Oral Transmucosal Drugs Sales Market Share by Application (2027-2032) Table 59. Global Oral Transmucosal Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Oral Transmucosal Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. Access Pharmaceutical Inc. Company Information Table 62. Access Pharmaceutical Inc. Business Overview Table 63. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Portfolio Table 65. Access Pharmaceutical Inc. Recent Development Table 66. Aquestive Therapeutics, Inc. Company Information Table 67. Aquestive Therapeutics, Inc. Business Overview Table 68. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Portfolio Table 70. Aquestive Therapeutics, Inc. Recent Development Table 71. Bristol-Myers Squibb Company Company Information Table 72. Bristol-Myers Squibb Company Business Overview Table 73. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Portfolio Table 75. Bristol-Myers Squibb Company Recent Development Table 76. C.L Pharm Company Information Table 77. C.L Pharm Business Overview Table 78. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. C.L Pharm Oral Transmucosal Drugs Product Portfolio Table 80. C.L Pharm Recent Development Table 81. Cure Pharmaceutical Company Information Table 82. Cure Pharmaceutical Business Overview Table 83. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cure Pharmaceutical Oral Transmucosal Drugs Product Portfolio Table 85. Cure Pharmaceutical Recent Development Table 86. Eisai Co., Ltd. Company Information Table 87. Eisai Co., Ltd. Business Overview Table 88. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eisai Co., Ltd. Oral Transmucosal Drugs Product Portfolio Table 90. Eisai Co., Ltd. Recent Development Table 91. IntelGenx Corp. Company Information Table 92. IntelGenx Corp. Business Overview Table 93. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. IntelGenx Corp. Oral Transmucosal Drugs Product Portfolio Table 95. IntelGenx Corp. Recent Development Table 96. LTS Lohmann Therapie-Systeme AG Company Information Table 97. LTS Lohmann Therapie-Systeme AG Business Overview Table 98. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Portfolio Table 100. LTS Lohmann Therapie-Systeme AG Recent Development Table 101. NAL Pharma Company Information Table 102. NAL Pharma Business Overview Table 103. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NAL Pharma Oral Transmucosal Drugs Product Portfolio Table 105. NAL Pharma Recent Development Table 106. Otsuka Pharmaceutical Co., Ltd. Company Information Table 107. Otsuka Pharmaceutical Co., Ltd. Business Overview Table 108. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Portfolio Table 110. Otsuka Pharmaceutical Co., Ltd. Recent Development Table 111. Soligenix Company Information Table 112. Soligenix Business Overview Table 113. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Soligenix Oral Transmucosal Drugs Product Portfolio Table 115. Soligenix Recent Development Table 116. Viatris Company Information Table 117. Viatris Business Overview Table 118. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Viatris Oral Transmucosal Drugs Product Portfolio Table 120. Viatris Recent Development Table 121. ZIM Laboratories Limited Company Information Table 122. ZIM Laboratories Limited Business Overview Table 123. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. ZIM Laboratories Limited Oral Transmucosal Drugs Product Portfolio Table 125. ZIM Laboratories Limited Recent Development Table 126. GlaxoSmithKline plc Company Information Table 127. GlaxoSmithKline plc Business Overview Table 128. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. GlaxoSmithKline plc Oral Transmucosal Drugs Product Portfolio Table 130. GlaxoSmithKline plc Recent Development Table 131. Teva Pharmaceutical Industries Ltd. Company Information Table 132. Teva Pharmaceutical Industries Ltd. Business Overview Table 133. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Portfolio Table 135. Teva Pharmaceutical Industries Ltd. Recent Development Table 136. North America Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 139. North America Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 140. North America Oral Transmucosal Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 141. North America Oral Transmucosal Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 142. North America Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 145. North America Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 146. North America Oral Transmucosal Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 147. North America Oral Transmucosal Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 148. North America Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. North America Oral Transmucosal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. North America Oral Transmucosal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. North America Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. North America Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units) Table 153. North America Oral Transmucosal Drugs Sales by Country (2027-2032) & (K Units) Table 154. North America Oral Transmucosal Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 155. North America Oral Transmucosal Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 156. United States Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 157. Canada Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 158. Europe Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 161. Europe Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 162. Europe Oral Transmucosal Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Europe Oral Transmucosal Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Europe Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 167. Europe Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 168. Europe Oral Transmucosal Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Europe Oral Transmucosal Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Europe Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Oral Transmucosal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Oral Transmucosal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Europe Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units) Table 175. Europe Oral Transmucosal Drugs Sales by Country (2027-2032) & (K Units) Table 176. Europe Oral Transmucosal Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Europe Oral Transmucosal Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Germany Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 179. France Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 180. U.K. Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 181. Italy Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 182. Netherlands Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 183. China Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 184. China Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 185. China Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 186. China Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 187. China Oral Transmucosal Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 188. China Oral Transmucosal Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 189. China Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 190. China Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 191. China Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 192. China Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 193. China Oral Transmucosal Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 194. China Oral Transmucosal Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 198. Asia Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 199. Asia Oral Transmucosal Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 200. Asia Oral Transmucosal Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 201. Asia Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 204. Asia Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 205. Asia Oral Transmucosal Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 206. Asia Oral Transmucosal Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Oral Transmucosal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Oral Transmucosal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. Asia Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units) Table 212. Asia Oral Transmucosal Drugs Sales by Country (2027-2032) & (K Units) Table 213. Asia Oral Transmucosal Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 214. Asia Oral Transmucosal Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Japan Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 216. South Korea Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 217. India Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 218. Australia Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 219. China Taiwan Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Oral Transmucosal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Oral Transmucosal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units) Table 224. SAMEA Oral Transmucosal Drugs Sales by Type (2027-2032) & (K Units) Table 225. SAMEA Oral Transmucosal Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 226. SAMEA Oral Transmucosal Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 227. SAMEA Oral Transmucosal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Oral Transmucosal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units) Table 230. SAMEA Oral Transmucosal Drugs Sales by Application (2027-2032) & (K Units) Table 231. SAMEA Oral Transmucosal Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 232. SAMEA Oral Transmucosal Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 233. SAMEA Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Oral Transmucosal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Oral Transmucosal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 237. SAMEA Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units) Table 238. SAMEA Oral Transmucosal Drugs Sales by Country (2027-2032) & (K Units) Table 239. SAMEA Oral Transmucosal Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 240. SAMEA Oral Transmucosal Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 241. Brazil Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 242. Argentina Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 243. Chile Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 244. Colombia Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 245. Peru Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 247. Israel Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 248. UAE Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 249. Turkey Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 250. Iran Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 251. Egypt Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Oral Transmucosal Drugs Distributors List Table 255. Oral Transmucosal Drugs Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Oral Transmucosal Drugs Image Figure 2. Global Oral Transmucosal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Transmucosal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Spray Image Figure 5. Tablets Image Figure 6. Gels Image Figure 7. Films Image Figure 8. Others Image Figure 9. Global Oral Transmucosal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Oral Transmucosal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Cardiovascular Disorders Image Figure 12. Diabetes Image Figure 13. Acute Pain Managements Image Figure 14. Others Image Figure 15. Global Oral Transmucosal Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Oral Transmucosal Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Oral Transmucosal Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Oral Transmucosal Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Oral Transmucosal Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Oral Transmucosal Drugs Sales (2021-2032) & (K Units) Figure 21. Global Oral Transmucosal Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Oral Transmucosal Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Oral Transmucosal Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Europe Oral Transmucosal Drugs Sales YoY (2021-2032) & (K Units) Figure 25. China Oral Transmucosal Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Oral Transmucosal Drugs Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Oral Transmucosal Drugs Sales YoY (2021-2032) & (K Units) Figure 28. Global Oral Transmucosal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Oral Transmucosal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Oral Transmucosal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Oral Transmucosal Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Oral Transmucosal Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Oral Transmucosal Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Oral Transmucosal Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Oral Transmucosal Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Oral Transmucosal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Oral Transmucosal Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Oral Transmucosal Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Oral Transmucosal Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Oral Transmucosal Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Oral Transmucosal Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Oral Transmucosal Drugs Revenue Share by Type (2021-2032) Figure 44. North America Oral Transmucosal Drugs Sales Share by Type (2021-2032) Figure 45. North America Oral Transmucosal Drugs Revenue Share by Application (2021-2032) Figure 46. North America Oral Transmucosal Drugs Sales Share by Application (2021-2032) Figure 47. North America Oral Transmucosal Drugs Revenue Share by Country (2021-2032) Figure 48. North America Oral Transmucosal Drugs Sales Share by Country (2021-2032) Figure 49. Europe Oral Transmucosal Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Oral Transmucosal Drugs Sales Share by Type (2021-2032) Figure 51. Europe Oral Transmucosal Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Oral Transmucosal Drugs Sales Share by Application (2021-2032) Figure 53. Europe Oral Transmucosal Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Oral Transmucosal Drugs Sales Share by Country (2021-2032) Figure 55. China Oral Transmucosal Drugs Revenue Share by Type (2021-2032) Figure 56. China Oral Transmucosal Drugs Sales Share by Type (2021-2032) Figure 57. China Oral Transmucosal Drugs Revenue Share by Application (2021-2032) Figure 58. China Oral Transmucosal Drugs Sales Share by Application (2021-2032) Figure 59. Asia Oral Transmucosal Drugs Revenue Share by Type (2021-2032) Figure 60. Asia Oral Transmucosal Drugs Sales Share by Type (2021-2032) Figure 61. Asia Oral Transmucosal Drugs Revenue Share by Application (2021-2032) Figure 62. Asia Oral Transmucosal Drugs Sales Share by Application (2021-2032) Figure 63. Asia Oral Transmucosal Drugs Revenue Share by Country (2021-2032) Figure 64. Asia Oral Transmucosal Drugs Sales Share by Country (2021-2032) Figure 65. SAMEA Oral Transmucosal Drugs Revenue Share by Type (2021-2032) Figure 66. SAMEA Oral Transmucosal Drugs Sales Share by Type (2021-2032) Figure 67. SAMEA Oral Transmucosal Drugs Revenue Share by Application (2021-2032) Figure 68. SAMEA Oral Transmucosal Drugs Sales Share by Application (2021-2032) Figure 69. SAMEA Oral Transmucosal Drugs Revenue Share by Country (2021-2032) Figure 70. SAMEA Oral Transmucosal Drugs Sales Share by Country (2021-2032) Figure 71. Oral Transmucosal Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Oral Transmucosal Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Spray
  • Tablets
  • Gels
  • Films
  • Others
Applications
  • Cardiovascular Disorders
  • Diabetes
  • Acute Pain Managements
  • Others
Companies covered
  • Access Pharmaceutical Inc.
  • Aquestive Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • C.L Pharm
  • Cure Pharmaceutical
  • Eisai Co., Ltd.
  • IntelGenx Corp.
  • LTS Lohmann Therapie-Systeme AG
  • NAL Pharma
  • Otsuka Pharmaceutical Co., Ltd.
  • Soligenix
  • Viatris
  • ZIM Laboratories Limited
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Transmucosal Drugs Market by Type
  3. 1.2.1 Global Oral Transmucosal Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid Spray
  5. 1.2.3 Tablets
  6. 1.2.4 Gels
  7. 1.2.5 Films
  8. 1.2.6 Others
  9. 1.3 Oral Transmucosal Drugs Market by Application
  10. 1.3.1 Global Oral Transmucosal Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Cardiovascular Disorders
  12. 1.3.3 Diabetes
  13. 1.3.4 Acute Pain Managements
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Oral Transmucosal Drugs Market Dynamics
  1. 2.1 Oral Transmucosal Drugs Industry Trends
  2. 2.2 Oral Transmucosal Drugs Industry Drivers
  3. 2.3 Oral Transmucosal Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Transmucosal Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Transmucosal Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Transmucosal Drugs Revenue by Region
  3. 3.2.1 Global Oral Transmucosal Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Transmucosal Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Transmucosal Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Transmucosal Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Transmucosal Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Transmucosal Drugs Sales by Region
  9. 3.4.1 Global Oral Transmucosal Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Transmucosal Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Transmucosal Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Transmucosal Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Transmucosal Drugs Revenue by Manufacturers
  2. 4.1.1 Global Oral Transmucosal Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Transmucosal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Transmucosal Drugs Sales by Manufacturers
  6. 4.2.1 Global Oral Transmucosal Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Transmucosal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Transmucosal Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Transmucosal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Transmucosal Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Transmucosal Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Oral Transmucosal Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Transmucosal Drugs Market CR5 and HHI
  16. 4.8.2 2025 Oral Transmucosal Drugs Tier 1, Tier 2, and Tier 3
5 Oral Transmucosal Drugs Market by Type
  1. 5.1 Global Oral Transmucosal Drugs Revenue by Type
  2. 5.1.1 Global Oral Transmucosal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Transmucosal Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Transmucosal Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Transmucosal Drugs Sales by Type
  6. 5.2.1 Global Oral Transmucosal Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Transmucosal Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oral Transmucosal Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Transmucosal Drugs Price by Type
6 Oral Transmucosal Drugs Market by Application
  1. 6.1 Global Oral Transmucosal Drugs Revenue by Application
  2. 6.1.1 Global Oral Transmucosal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Transmucosal Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Transmucosal Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Transmucosal Drugs Sales by Application
  6. 6.2.1 Global Oral Transmucosal Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Transmucosal Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oral Transmucosal Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Transmucosal Drugs Price by Application
7 Company Profiles
  1. 7.1 Access Pharmaceutical Inc.
  2. 7.1.1 Access Pharmaceutical Inc. Company Information
  3. 7.1.2 Access Pharmaceutical Inc. Business Overview
  4. 7.1.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Portfolio
  6. 7.1.5 Access Pharmaceutical Inc. Recent Developments
  7. 7.2 Aquestive Therapeutics, Inc.
  8. 7.2.1 Aquestive Therapeutics, Inc. Company Information
  9. 7.2.2 Aquestive Therapeutics, Inc. Business Overview
  10. 7.2.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Portfolio
  12. 7.2.5 Aquestive Therapeutics, Inc. Recent Developments
  13. 7.3 Bristol-Myers Squibb Company
  14. 7.3.1 Bristol-Myers Squibb Company Company Information
  15. 7.3.2 Bristol-Myers Squibb Company Business Overview
  16. 7.3.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 7.4 C.L Pharm
  20. 7.4.1 C.L Pharm Company Information
  21. 7.4.2 C.L Pharm Business Overview
  22. 7.4.3 C.L Pharm Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 C.L Pharm Oral Transmucosal Drugs Product Portfolio
  24. 7.4.5 C.L Pharm Recent Developments
  25. 7.5 Cure Pharmaceutical
  26. 7.5.1 Cure Pharmaceutical Company Information
  27. 7.5.2 Cure Pharmaceutical Business Overview
  28. 7.5.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cure Pharmaceutical Oral Transmucosal Drugs Product Portfolio
  30. 7.5.5 Cure Pharmaceutical Recent Developments
  31. 7.6 Eisai Co., Ltd.
  32. 7.6.1 Eisai Co., Ltd. Company Information
  33. 7.6.2 Eisai Co., Ltd. Business Overview
  34. 7.6.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eisai Co., Ltd. Oral Transmucosal Drugs Product Portfolio
  36. 7.6.5 Eisai Co., Ltd. Recent Developments
  37. 7.7 IntelGenx Corp.
  38. 7.7.1 IntelGenx Corp. Company Information
  39. 7.7.2 IntelGenx Corp. Business Overview
  40. 7.7.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 IntelGenx Corp. Oral Transmucosal Drugs Product Portfolio
  42. 7.7.5 IntelGenx Corp. Recent Developments
  43. 7.8 LTS Lohmann Therapie-Systeme AG
  44. 7.8.1 LTS Lohmann Therapie-Systeme AG Company Information
  45. 7.8.2 LTS Lohmann Therapie-Systeme AG Business Overview
  46. 7.8.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Portfolio
  48. 7.8.5 LTS Lohmann Therapie-Systeme AG Recent Developments
  49. 7.9 NAL Pharma
  50. 7.9.1 NAL Pharma Company Information
  51. 7.9.2 NAL Pharma Business Overview
  52. 7.9.3 NAL Pharma Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 NAL Pharma Oral Transmucosal Drugs Product Portfolio
  54. 7.9.5 NAL Pharma Recent Developments
  55. 7.10 Otsuka Pharmaceutical Co., Ltd.
  56. 7.10.1 Otsuka Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Portfolio
  60. 7.10.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Soligenix
  62. 7.11.1 Soligenix Company Information
  63. 7.11.2 Soligenix Business Overview
  64. 7.11.3 Soligenix Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Soligenix Oral Transmucosal Drugs Product Portfolio
  66. 7.11.5 Soligenix Recent Developments
  67. 7.12 Viatris
  68. 7.12.1 Viatris Company Information
  69. 7.12.2 Viatris Business Overview
  70. 7.12.3 Viatris Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Viatris Oral Transmucosal Drugs Product Portfolio
  72. 7.12.5 Viatris Recent Developments
  73. 7.13 ZIM Laboratories Limited
  74. 7.13.1 ZIM Laboratories Limited Company Information
  75. 7.13.2 ZIM Laboratories Limited Business Overview
  76. 7.13.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ZIM Laboratories Limited Oral Transmucosal Drugs Product Portfolio
  78. 7.13.5 ZIM Laboratories Limited Recent Developments
  79. 7.14 GlaxoSmithKline plc
  80. 7.14.1 GlaxoSmithKline plc Company Information
  81. 7.14.2 GlaxoSmithKline plc Business Overview
  82. 7.14.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 GlaxoSmithKline plc Oral Transmucosal Drugs Product Portfolio
  84. 7.14.5 GlaxoSmithKline plc Recent Developments
  85. 7.15 Teva Pharmaceutical Industries Ltd.
  86. 7.15.1 Teva Pharmaceutical Industries Ltd. Company Information
  87. 7.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
  88. 7.15.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Portfolio
  90. 7.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
8 North America
  1. 8.1 North America Oral Transmucosal Drugs Market Size by Type
  2. 8.1.1 North America Oral Transmucosal Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Transmucosal Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Transmucosal Drugs Price by Type (2021-2032)
  5. 8.2 North America Oral Transmucosal Drugs Market Size by Application
  6. 8.2.1 North America Oral Transmucosal Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Transmucosal Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Transmucosal Drugs Price by Application (2021-2032)
  9. 8.3 North America Oral Transmucosal Drugs Market Size by Country
  10. 8.3.1 North America Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Transmucosal Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Oral Transmucosal Drugs Market Size by Type
  2. 9.1.1 Europe Oral Transmucosal Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Transmucosal Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Transmucosal Drugs Price by Type (2021-2032)
  5. 9.2 Europe Oral Transmucosal Drugs Market Size by Application
  6. 9.2.1 Europe Oral Transmucosal Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Transmucosal Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Transmucosal Drugs Price by Application (2021-2032)
  9. 9.3 Europe Oral Transmucosal Drugs Market Size by Country
  10. 9.3.1 Europe Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Transmucosal Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Oral Transmucosal Drugs Market Size by Type
  2. 10.1.1 China Oral Transmucosal Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Transmucosal Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Oral Transmucosal Drugs Price by Type (2021-2032)
  5. 10.2 China Oral Transmucosal Drugs Market Size by Application
  6. 10.2.1 China Oral Transmucosal Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Transmucosal Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Oral Transmucosal Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Transmucosal Drugs Market Size by Type
  2. 11.1.1 Asia Oral Transmucosal Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Transmucosal Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Transmucosal Drugs Price by Type (2021-2032)
  5. 11.2 Asia Oral Transmucosal Drugs Market Size by Application
  6. 11.2.1 Asia Oral Transmucosal Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Transmucosal Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Transmucosal Drugs Price by Application (2021-2032)
  9. 11.3 Asia Oral Transmucosal Drugs Market Size by Country
  10. 11.3.1 Asia Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Transmucosal Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Transmucosal Drugs Market Size by Type
  2. 12.1.1 SAMEA Oral Transmucosal Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Transmucosal Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Transmucosal Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Transmucosal Drugs Market Size by Application
  6. 12.2.1 SAMEA Oral Transmucosal Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Transmucosal Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Transmucosal Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Transmucosal Drugs Market Size by Country
  10. 12.3.1 SAMEA Oral Transmucosal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Transmucosal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Transmucosal Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Transmucosal Drugs Value Chain Analysis
  2. 13.1.1 Oral Transmucosal Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Transmucosal Drugs Production Mode & Process
  6. 13.2 Oral Transmucosal Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Transmucosal Drugs Distributors
  9. 13.2.3 Oral Transmucosal Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst